Clinical Effectiveness of Traditional and Complementary Medicine Interventions in Combination with Nicotine Replacement Therapy on Smoking Cessation: A Randomized Controlled Pilot Trial.

Plain-language guide to PMID 31017453 (2019): open-label randomized controlled trial of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID: 31017453
Journal: Journal of alternative and complementary medicine (New York, N.Y.)
Year: 2019
Study type: Randomized Controlled Trial
Authors: Jang S et al. (6 authors)
DOI: 10.1089/acm.2019.0009

What This Study Did, in Plain Language

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in this randomized controlled trial publication.

Methods: The study design was a pragmatic, open-label randomized trial.

Who Took Part

The age groups tagged for this paper are young adults, adults, middle-aged adults and older adults, both men and women.

The intervention group was provided T&CM interventions in addition to nicotine replacement therapy (NRT) and counseling, whereas the control group was treated with only NRT and counseling.

Results: Forty-one participants were enrolled and assigned to either an intervention group or a control group at a ratio of 1:1.

How the Study Was Run

The design is described as randomized, open-label and pilot.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

Everyone knew when Therapeutic nicotine (patch, non-peptide) was being given (open label), which is simpler to run but leaves more room for expectations to affect what is reported.

It is described as a pilot, a small early test of whether a larger Therapeutic nicotine (patch, non-peptide) study would be practical.

What Was Measured

PubMed files the paper under topics including Acupuncture Therapy, Aromatherapy, Pilot Projects, Smoking Cessation, Substance Withdrawal Syndrome and Tobacco Use Cessation Devices.

Author keywords: complementary medicine, tobacco control and traditional medicine.

What This Means in Plain Language

The paper is a randomized, open-label and pilot study of Therapeutic nicotine (patch, non-peptide).

The publication is from 2019 (Journal of alternative and complementary medicine (New York, N.Y.)), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Therapeutic nicotine (patch, non-peptide) in the library

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.